| Secondary |
| Drug Use For Unknown Indication |
33.3% |
| Blood Cholesterol Increased |
12.5% |
| Hypercholesterolaemia |
8.3% |
| Hypertension |
8.3% |
| Peritoneal Dialysis |
8.3% |
| Smoking Cessation Therapy |
8.3% |
| Angina Pectoris |
4.2% |
| Breast Cancer |
4.2% |
| Bronchitis |
4.2% |
| Haemorrhage |
4.2% |
| Percutaneous Coronary Intervention |
4.2% |
|
| Myocardial Infarction |
16.7% |
| Blood Creatine Phosphokinase Increased |
8.3% |
| Chest Pain |
8.3% |
| Gamma-glutamyltransferase Increased |
8.3% |
| Liver Function Test Abnormal |
8.3% |
| Myopathy |
8.3% |
| Pain In Extremity |
8.3% |
| Rhabdomyolysis |
8.3% |
| Thrombocytopenia |
8.3% |
| Unevaluable Event |
8.3% |
| Vomiting |
8.3% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
24.0% |
| Hypertension |
20.2% |
| Product Used For Unknown Indication |
15.4% |
| Diabetes Mellitus |
9.8% |
| Atrial Fibrillation |
4.4% |
| Drug Use For Unknown Indication |
4.3% |
| Hyperlipidaemia |
4.0% |
| Coronary Artery Disease |
3.2% |
| Cardiac Failure |
2.6% |
| Depression |
2.0% |
| Prostate Cancer |
1.6% |
| Cerebral Infarction |
1.4% |
| Infected Skin Ulcer |
1.1% |
| Renal Failure |
1.0% |
| Arthritis Bacterial |
0.9% |
| Blood Cholesterol Increased |
0.9% |
| Cardiomyopathy |
0.9% |
| Device Therapy |
0.9% |
| Transient Ischaemic Attack |
0.9% |
| Angina Pectoris |
0.7% |
|
| Cardiac Failure Congestive |
9.9% |
| Cerebral Infarction |
7.7% |
| Acute Myocardial Infarction |
6.6% |
| Fatigue |
6.6% |
| Neoplasm Malignant |
6.6% |
| Anaemia |
5.5% |
| Cardiac Failure |
5.5% |
| Hypoglycaemia |
5.5% |
| Sudden Death |
5.5% |
| Cerebral Haemorrhage |
4.4% |
| Melaena |
4.4% |
| Myocardial Infarction |
4.4% |
| Transient Ischaemic Attack |
4.4% |
| Angina Pectoris |
3.3% |
| Cataract |
3.3% |
| Chest Discomfort |
3.3% |
| Constipation |
3.3% |
| Dyspnoea |
3.3% |
| Fall |
3.3% |
| Haematuria |
3.3% |
|
| Interacting |
| Blood Pressure |
33.3% |
| Type 2 Diabetes Mellitus |
33.3% |
| Chronic Myeloid Leukaemia |
16.7% |
| Dyslipidaemia |
16.7% |
|
| Suicidal Ideation |
50.0% |
| Restlessness |
25.0% |
| Rhabdomyolysis |
25.0% |
|
